Reference health

Na+,K+-ATPase activity in an animal model of mania

https://doi.org/10.1007/s00702-009-0198-9
CiteStamped reference-health badge
44/44 checkable references clean · checked 2026-07-22

Every reference with a DOI in the deposited reference list resolved to a known work in Crossref or DataCite at the dated check, and none carried a retraction, withdrawal, or removal notice.

2 without a DOI — not checked. A reference deposited without a DOI is never matched by title or guessed at; it stays outside the checked set, and this line discloses that.

The 44 checked references that resolve
resolves10.1176/appi.ajp.157.7.1108
Brain SPECT Imaging of Amphetamine-Induced Dopamine Release in Euthymic Bipolar Disorder Patients
resolves10.1073/pnas.0307921101
Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade
resolves10.1002/hup.665
Lithium and valproate attenuate dextroamphetamine-induced changes in brain activation
resolves10.1056/NEJMra035354
Bipolar Disorder
resolves10.1177/070674370204700203
The Neurobiology of Bipolar Disorder: Focus on Signal Transduction Pathways and the Regulation of Gene Expression
resolves10.1017/S1461145708008833
Chronic d-amphetamine depresses an imaging marker of arachidonic acid metabolism in rat brain
resolves10.1016/0003-2697(86)90640-8
A direct colorimetric assay for Ca2+-stimulated ATPase activity
resolves10.1046/j.1471-4159.2001.00311.x
Chronic valproate treatment decreases the <i>in vivo</i> turnover of arachidonic acid in brain phospholipids: a possible common effect of mood stabilizers
resolves10.1007/BF00167447
Inhibition of Na+, K+-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation
resolves10.1016/j.pnpbp.2007.02.005
Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania
resolves10.1016/S0896-6273(03)00195-8
Finding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments
resolves10.1523/JNEUROSCI.23-19-07311.2003
The Role of the Extracellular Signal-Regulated Kinase Signaling Pathway in Mood Modulation
resolves10.1016/0301-0082(94)90015-9
Ions and energy in mammalian brain
resolves10.1126/science.281.5378.838
DARPP-32: Regulator of the Efficacy of Dopaminergic Neurotransmission
resolves10.1016/j.lfs.2006.01.002
Effects of mood stabilizers on hippocampus BDNF levels in an animal model of mania
resolves10.1023/A:1024988113978
Reduction of Hippocampal Na+, K+-ATPase Activity in Rats Subjected to an Experimental Model of Depression
resolves10.1016/j.biopsych.2005.12.021
Involvement of Na+, K+-ATPase and Endogenous Digitalis-Like Compounds in Depressive Disorders
resolves10.1177/107385802237176
The Wnt Signaling Pathway in Bipolar Disorder
resolves10.1002/ana.410160719
Glial and neuronal Na+-K+ pump in epilepsy
resolves10.1016/0005-2736(74)90268-5
Isolation of synaptic plasma membrane from brain by combined flotation-sedimentation density gradient centrifugation
resolves10.1034/j.1399-5618.2000.020305.x
Mitochondrial dysfunction in bipolar disorder
resolves10.1016/j.pnpbp.2008.05.027
Dose-dependent effect of intracerebroventricular injection of ouabain on the phosphorylation of the MEK1/2-ERK1/2-p90RSK pathway in the rat brain related to locomotor activity
resolves10.1001/archpsyc.61.3.300
Molecular Evidence for Mitochondrial Dysfunction in Bipolar Disorder
resolves10.1001/jama.293.20.2528
The Increasing Medical Burden in Bipolar Disorder
resolves10.1080/00207450290025978
MEMBRANE Na &amp;#180 +;-K &amp;#180 +; ATPase MEDIATED CASCADE IN BIPOLAR MOOD DISORDER, MAJOR DEPRESSIVE DISORDER, AND SCHIZOPHRENIA RELATIONSHIP TO HEMISPHERIC DOMINANCE
resolves10.1016/0306-4522(93)90254-D
Contributory mechanisms in the causation of neurodegenerative disorders
resolves10.1016/j.pnpbp.2003.10.015
Perspectives for the development of animal models of bipolar disorder
resolves10.1046/j.1471-4159.2002.00939.x
BDNF‐mediated signal transduction is modulated by GSK3β and mood stabilizing agents
resolves10.1038/sj.mp.4001018
PKC, MAP kinases and the bcl-2 family of proteins as long-term targets for mood stabilizers
resolves10.1016/S0006-3223(00)00929-X
Signaling: cellular insights into the pathophysiology of bipolar disorder
resolves10.1038/87865
The cellular neurobiology of depression
resolves10.1111/j.1399-5618.2007.00354.x
Effects of mood stabilizers on the inhibition of adenylate cyclase via dopamine D<sub>2</sub>‐like receptors
resolves10.1016/S0140-6736(02)07450-0
Bipolar disorder
resolves10.1016/S0006-3223(97)00454-X
Progressive behavioral response to repeated d-amphetamine challenge: further evidence for sensitization in humans
resolves10.1023/A:1021670607647
Reduction of Na+,K+-ATPase Activity in Hippocampus of Rats Subjected to Chemically Induced Hyperhomocysteinemia
resolves10.1016/j.lfs.2007.11.026
Brain creatine kinase activity in an animal model of mania
resolves10.1152/jn.00244.2002
Mechanisms of Neuronal Hyperexcitability Caused by Partial Inhibition of Na<sup>+</sup>-K<sup>+</sup>-ATPases in the Rat CA1 Hippocampal Region
resolves10.1016/j.lfs.2004.09.004
Endobain E, a brain Na+, K+-ATPase inhibitor, decreases norepinephrine uptake in rat hypothalamus
resolves10.1042/bst023227s
Alanine reverses the inhibitory effect of phenylalanine and its metabolites on Na+,K+-ATPase in synaptic plasma membranes from cerebral cortex of rats
resolves10.1023/A:1021647329937
Inhibition of Na+,K+-ATPase Activity in Hippocampus of Rats Subjected to Acute Administration of Homocysteine Is Prevented by Vitamins E and C Treatment
resolves10.1016/S0026-895X(25)08721-8
Dopamine D2L receptors stimulate Na+/K(+)-ATPase activity in murine LTK- cells.
resolves10.1016/j.neuropharm.2007.08.018
Lithium inhibits function of voltage-dependent sodium channels and catecholamine secretion independent of glycogen synthase kinase-3 in adrenal chromaffin cells
resolves10.1038/sj.jcbfm.9600440
Dopamine Receptor Modulation of Hypoxic—Ischemic Neuronal Injury in Striatum of Newborn Piglets
resolves10.1016/S0736-5748(03)00038-8
Inhibition of Na<sup>+</sup>, K<sup>+</sup>‐ATPase activity in rat striatum by guanidinoacetate
The 2 references without a DOI — listed, not checked
no DOI — not checkedJacobsen FM (1993) Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry 54:229–234
no DOI — not checkedWyse ATS, Streck EL, Barros SVT et al (2000) Methylmalonate administration decreases Na+,K+-ATPase activity in cerebral cortex of rats. Neuroreport 11:2311–2315
What this badge says. CiteStamped means the CHECKABLE references of this work were clean at the dated check: each resolved to a known work in a public registry, and none carried a retraction notice at that time. It says nothing about the quality, findings, or importance of the work itself, and nothing about references deposited without a DOI.

checked 2026-07-22 — re-checked daily as this page is visited; titles and statuses come from Crossref and DataCite and are not part of the signed record

Embed this badge

Both snippets point at the live badge image and link back to this page. The badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.

<a href="https://citestamp.com/citestamped/10.1007/s00702-009-0198-9"><img src="https://citestamp.com/citestamped/10.1007/s00702-009-0198-9/badge.svg" alt="CiteStamped reference-health badge" width="460" height="64"></a>
[![CiteStamped reference-health badge](https://citestamp.com/citestamped/10.1007/s00702-009-0198-9/badge.svg)](https://citestamp.com/citestamped/10.1007/s00702-009-0198-9)